E. Lain

发表

Extended Safety Analysis of Baricitinib 2 mg in Adult Patients with Atopic Dermatitis: An Integrated Analysis from Eight Randomized Clinical Trials

J. Silverberg, B. King, E. Simpson, 2021, American Journal of Clinical Dermatology.

Efficacy and Safety of Topical Hypericin Photodynamic Therapy for Early-Stage Cutaneous T-Cell Lymphoma (Mycosis Fungoides): The FLASH Phase 3 Randomized Clinical Trial.

O. Akilov, O. Donini, T. Kuzel, 2022, JAMA dermatology.

Treatment of Rosacea With Concomitant Use of Topical Ivermectin 1% Cream and Brimonidine 0.33% Gel: A Randomized, Vehicle-controlled Study.

M. Gooderham, K. Papp, C. Lynde, 2017, Journal of drugs in dermatology : JDD.

Disseminated nocardiosis caused by Nocardia transvalensis in a patient with mixed immunodeficiency.

M. J. Revillo, E. Lain, S. Ruiz, 2015, Revista clinica espanola.

Evaluation of Psychological Wellbeing and Social Impact of Combined Facial and Truncal Acne: a Multi-national, Mixed-Methods Study

B. Dréno, S. Beissert, R. Chavda, 2022, Dermatology and Therapy.

Evaluation of psychological well-being and social impact of atrophic acne scarring: A multinational, mixed-methods study

B. Dréno, S. Beissert, Jerry Tan, 2021, JAAD international.

Efficacy of brodalumab in the treatment of scalp and nail psoriasis: results from three phase 3 trials

B. Elewski, P. Rich, E. Lain, 2020, The Journal of dermatological treatment.

Meibomian Gland Dysfunction: A Dermatological Perspective on Pathogenesis and Treatment Outlook

Terry Kim, J. Hovanesian, Preeya K Gupta, 2021, Clinical ophthalmology.

Efficacy, Safety, and Patient Satisfaction with a Combined Acne TreatmentRegimen for the Treatment of Acne Vulgaris in Adolescent Student Athletes

B. Adams, E. Lain, M. Rueda, 2016 .

Impact of facial and truncal acne on quality of life: A multi-country population-based survey

B. Dréno, S. Beissert, Jerry Tan, 2021, JAAD international.

Agminated Spitz Nevi: Report of a Child with a Unique Dermatomal Distribution

J. Kincannon, E. Lain, M. Glasgow, 2005, Pediatric dermatology.

Safety and Tolerability of Sarecycline for the Treatment of Acne Vulgaris: Results from a Phase III, Multicenter, Open-Label Study and a Phase I Phototoxicity Study.

D. Pariser, C. Schmitz, L. Green, 2019, The Journal of clinical and aesthetic dermatology.

Efficacy and Safety of a Novel Topical Minocycline Foam for the Treatment of Moderate-to-Severe Acne Vulgaris: A Phase 3 Study.

I. Stuart, L. Kircik, A. Moore, 2020, Journal of the American Academy of Dermatology.

Tretinoin 0.05% Lotion for the Once-Daily Treatment of Moderate-to-Severe Acne Vulgaris: Impact of Gender and Race on Efficacy and Safety

D. Day, J. Harper, E. Guenin, 2019, Journal of drugs in dermatology : JDD.

Novel Tretinoin 0.05% Lotion for the Once-daily Treatment of Moderate-to-Severe Acne Vulgaris in an Adult and Adolescent Female Population

L. Kircik, H. Baldwin, E. Guenin, 2019, Journal of drugs in dermatology : JDD.

Safety and Tolerability of Sarecycline for the Treatment of Acne Vulgaris

A. Grada, D. Pariser, C. Schmitz, 2020 .

Evidence of Barrier Deficiency in Rosacea and the Importance of Integrating OTC Skincare Products into Treatment Regimens

Jerry Tan, A. Alexis, H. Baldwin, 2022, Journal of Drugs in Dermatology.

Trifarotene 0.005% Cream in the Treatment of Facial and Truncal Acne Vulgaris in Patients with Skin of Color: a Case Series

A. Alexis, J. D. Del Rosso, E. Lain, 2022, Dermatology and Therapy.

Phase 3 Trials of Tirbanibulin Ointment for Actinic Keratosis.

S. Forman, A. Blauvelt, S. Tyring, 2021, The New England journal of medicine.

Efficacy and Safety of a Fixed-Dose Clindamycin Phosphate 1.2%, Benzoyl Peroxide 3.1%, and Adapalene 0.15% Gel for Moderate-to-Severe Acne: A Randomized Phase II Study of the First Triple-Combination Drug

N. Sadick, Z. Draelos, M. Gold, 2021, American Journal of Clinical Dermatology.

Imiquimod treatment of exuberant granulation tissue in a nonhealing diabetic ulcer.

E. Lain, P. Carrington, 2005, Archives of dermatology.

Early and explosive development of nodular basal cell carcinoma and multiple keratoacanthomas in psoriasis patients treated with cyclosporine.

Ramsey F Markus, E. Lain, 2004, Journal of drugs in dermatology : JDD.

The Role of Topical Retinoids in Prevention and Treatment of Atrophic Acne Scarring: Understanding the Importance of Early Effective Treatment

Jerry Tan, E. Tanghetti, H. Baldwin, 2019, Journal of drugs in dermatology : JDD.

Safety and Efficacy of Nano‐Pulse Stimulation Treatment of Non‐Genital, Cutaneous Warts (Verrucae)

R. Nuccitelli, E. Ross, E. Lain, 2021, Lasers in surgery and medicine.

Impact of Facial Atrophic Acne Scars on Quality of Life: A Multi-country Population-Based Survey

B. Dréno, S. Beissert, A. Layton, 2021, American Journal of Clinical Dermatology.

Pivotal Trial of the Efficacy and Safety of Oxymetazoline Cream 1.0% for the Treatment of Persistent Facial Erythema Associated With Rosacea: Findings from the Second REVEAL Trial.

L. Baumann, D. Goldberg, Joely Kaufman, 2018, Journal of drugs in dermatology : JDD.

Eosinophilic cellulitislike reaction to subcutaneous etanercept injection.

T. Horn, Thomas Horn, Harry Winfield, 2006, Archives of dermatology.

BPX-01 Minocycline Topical Gel Shows Promise for the Treatment of Moderate-to-severe Inflammatory Acne Vulgaris.

Z. Draelos, M. Gold, J. Fowler, 2018, The Journal of clinical and aesthetic dermatology.

Effects of Tazarotene 0.045% Lotion on Quality of Life in Patients With Moderate-to-Severe Acne.

M. Gold, L. Kircik, H. Baldwin, 2020, Journal of drugs in dermatology : JDD.

Efficacy of Roflumilast Foam, 0.3%, in Patients With Seborrheic Dermatitis: A Double-blind, Vehicle-Controlled Phase 2a Randomized Clinical Trial.

S. Forman, C. Lynde, L. Kircik, 2023, JAMA dermatology.

15908 Long-term efficacy and safety of brodalumab in patients with or without metabolic syndrome

B. Strober, L. Kircik, S. Guenthner, 2020 .

Clinical and Molecular Effects of Interleukin-17 Pathway Blockade in Psoriasis

A. Menter, J. Weinberg, E. Lain, 2020, Journal of drugs in dermatology : JDD.

Tirbanibulin Ointment 1% for Actinic Keratosis (AK): Pooled Data from Two Phase 3 Studies

M. Lebwohl, A. Blauvelt, D. Cutler, 2020 .

Triple‐combination clindamycin phosphate 1.2%/benzoyl peroxide 3.1%/adapalene 0.15% gel for moderate‐to‐severe acne in children and adolescents: Randomized phase 2 study

N. Sadick, M. Gooderham, K. Papp, 2023, Pediatric dermatology.

Once-daily Dapsone 7.5% Gel for the Treatment of Acne Vulgaris in Preadolescent Patients: A Phase IV, Open-label, 12-week Study.

A. Grada, L. Kircik, A. Moore, 2021, The Journal of clinical and aesthetic dermatology.

Efficacy and Safety of Adapalene 0.3%/Benzoyl Peroxide 2.5% Gel Plus Oral Doxycycline in Subjects With Severe Inflammatory Acne Who Are Candidates for Oral Isotretinoin.

J. Weiss, M. Rendon, E. Tanghetti, 2018, Journal of drugs in dermatology : JDD.

Topical Oxymetazoline Cream 1.0% for Persistent Facial Erythema Associated With Rosacea: Pooled Analysis of the Two Phase 3, 29-Day, Randomized, Controlled REVEAL Trials

L. Baumann, Z. Draelos, L. Kircik, 2018, Journal of drugs in dermatology : JDD.

Table of Contents

I. Stuart, L. Kircik, A. Moore, 2020, Journal of the American Academy of Dermatology.

Efficacy and safety of topical oxymetazoline cream 1.0% for the treatment of facial erythema associated with rosacea: Findings from 1 of 2 pivotal trials

Z. Draelos, D. Goldberg, L. Kircik, 2017 .

Limited Systemic Exposure with Topical Glycopyrronium Tosylate in Primary Axillary Hyperhidrosis

D. Mould, J. Drew, D. Pariser, 2021, Clinical Pharmacokinetics.

Integrated Safety and Efficacy Analysis of FMX103 1.5% Topical Minocycline Foam for the Treatment of Moderate-to-Severe Papulopustular Rosacea: Results From Two Phase 3 Studies

N. Sadick, I. Stuart, L. Kircik, 2020, SKIN The Journal of Cutaneous Medicine.